Patients have a stake in the relationship between doctors and pharmaceutical companies, so the CMA’s current review of its guidelines for doctor/pharma interactions is everybody’s business.
Academic rigour, journalistic flair
Articles on Doctor prescribing
Displaying all articles
When news reports tout a drug, people get interested, even if the benefits are unproven. Patient hopes, requests and demands can easily turn into real prescriptions in their doctor’s office.
Drug companies funded more than 116,000 educational events for doctors over four years. Now you can find out exactly which companies footed the bills and how much they paid.
A push towards prescribing generic medications rather than their branded equivalents, as flagged in the budget, may have benefits beyond simple cost savings.
An important new study in the United States has found doctors who receive just one cheap meal from a drug company tend to prescribe a lot more of that company’s products.
The view of many doctors that “I don’t let myself be influenced” might be the biggest barrier to change.
Top contributors
-
Associate professor, School of Pharmacy and Charles Perkins Centre, University of Sydney
-
Assistant Professor, Bond University
-
PhD student, University of Sydney
-
Chief Scientist, Center for Bioethics and Humanities and Professor of Medicine and Public Health, University of Colorado Anschutz Medical Campus
-
Joel Lexchin is a Friend of The Conversation.
Professor Emeritus of Health Policy and Management, York University, Canada
-
Associate professor, School of Public Policy and Administration, Carleton University
-
Assistant Professor (Status), University of Toronto
-
Professor of Health Policy and Internal Medicine, University of California, Davis
-
Palliative Medicine Physician, Senior Research Fellow, The University of Melbourne
